EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0002 (100.00%)
At close: Jul 9, 2026
EV Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 |
| 0 | 7 | 6 | 21 | 71 | - | |
Market Cap Growth | -99.56% | 6.82% | -70.36% | -71.13% | - | - |
Enterprise Value | - | 17 | -14 | 0 | 68 | - |
Last Close Price | 0.00 | 2.70 | 2.54 | 8.57 | 30.00 | - |
Price Ratios
Fiscal Year | Current | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 |
PE Ratio | - | - | - | - | 8.21 | - |
PS Ratio | 0.00 | 0.69 | 0.64 | 0.48 | 1.54 | - |
PB Ratio | 0.00 | 0.15 | 1.64 | 1.83 | 1.53 | - |
P/TBV Ratio | 0.00 | 0.16 | 3.69 | 2.26 | 1.71 | - |
P/FCF Ratio | - | - | - | - | 17.02 | - |
P/OCF Ratio | 0.00 | - | 3.93 | 1.55 | 11.49 | - |
EV Ratios
Fiscal Year | Current | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 |
EV/Sales Ratio | - | 1.75 | - | 0.01 | 1.47 | - |
EV/EBITDA Ratio | - | - | - | 0.09 | 4.66 | - |
EV/EBIT Ratio | - | 106.82 | - | 0.16 | 5.29 | - |
EV/FCF Ratio | - | - | - | - | 16.26 | - |
Financial Efficiency
Fiscal Year | Current | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 |
Debt / Equity Ratio | 0.15 | 0.15 | 3.19 | 1.04 | 0.33 | 0.52 |
Debt / EBITDA Ratio | - | - | - | 2.17 | 1.05 | 1.17 |
Debt / FCF Ratio | - | - | - | - | 3.66 | 1.72 |
Net Debt / Equity Ratio | -0.14 | -0.14 | 2.70 | 0.80 | -0.02 | -0.01 |
Net Debt / EBITDA Ratio | - | - | -3.09 | 1.67 | -0.08 | -0.02 |
Net Debt / FCF Ratio | - | - | -26.46 | -0.38 | -0.28 | -0.03 |
Asset Turnover | - | - | 0.27 | 0.75 | 0.63 | 0.70 |
Inventory Turnover | - | - | 26.51 | 71.77 | 74.69 | 74.71 |
Quick Ratio | 0.80 | 0.80 | 0.23 | 0.34 | 0.84 | 1.83 |
Current Ratio | 3.11 | 3.11 | 0.30 | 0.42 | 0.87 | 1.97 |
Return on Equity (ROE) | - | - | -99.17% | -183.68% | 20.59% | 33.15% |
Return on Assets (ROA) | - | - | -7.05% | 3.49% | 10.92% | 15.02% |
Return on Invested Capital (ROIC) | 0.62% | 0.62% | -23.11% | 9.69% | 23.28% | 30.17% |
Return on Capital Employed (ROCE) | 0.40% | 0.40% | -105.70% | 28.20% | 27.50% | 27.20% |
Yields
Fiscal Year | Current | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 |
Earnings Yield | -13486.09% | -8.47% | -121.91% | -258.71% | 12.19% | - |
FCF Yield | -9269.39% | - | -6.22% | -113.55% | 5.88% | - |
Buyback Yield / Dilution | -0.69% | - | -1.02% | -49.09% | - | - |